Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 2
2007 4
2008 6
2009 3
2010 3
2011 11
2012 26
2013 28
2014 43
2015 71
2016 61
2017 63
2018 50
2019 39
2020 28
2021 55
2022 44
2023 21
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 25242669

505 results

Results by year

Filters applied: . Clear all
Page 1
Rationale and study design of the IRENE-trial (NVALT-16): a phase II trial to evaluate iressa rechallenge in advanced NSCLC patients with an activating EGFR mutation who responded to an EGFR-TKI used as first-line or previous treatment.
Kuiper JL, Heideman DA, Würdinger T, Grünberg K, Groen HJ, Smit EF. Kuiper JL, et al. Clin Lung Cancer. 2015 Jan;16(1):60-6. doi: 10.1016/j.cllc.2014.07.008. Epub 2014 Aug 15. Clin Lung Cancer. 2015. PMID: 25242669 Clinical Trial.
A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test.
Choi MK, Hong JY, Chang WJ, Kim MJ, Kim SM, Jung HA, Do IG, Choi YL, Sun JM, Ahn JS, Park K, Ahn MJ. Choi MK, et al. Cancer Chemother Pharmacol. 2015 Jun;75(6):1229-36. doi: 10.1007/s00280-015-2740-9. Epub 2015 Apr 23. Cancer Chemother Pharmacol. 2015. PMID: 25903122 Clinical Trial.
505 results